Supply Chain Risk Management: Moroccan Pharmaceutical Sector Case

Author:

MASSMAR Adil1

Affiliation:

1. ALTINBAŞ ÜNİVERSİTESİ

Abstract

Pharmaceutical systems are care settings characterized by the wide range of activities and scenarios with which they would be challenged. This causes interactions that result in unexpected scenarios associated with a variety of dangers such as variations in demand, risks associated with supplier relationships, and so on…. As a result, risk management appears to be a major issue for decision-makers. Today supply chain management needs to be dynamic and responsive to create added value, and mitigates these risks by using flexibility strategies to respond to change while remaining competitive. The goal of this research is to look into the supply and demand strategies used by pharmaceutical companies to respond to disruptions and avoid medicine interruptions for consumers. In this thesis the supply chain risk management strategies are basically connected to an empirical study done in 32 Moroccan pharmaceutical enterprises. Following that, the participants’ responses were based on a questionnaire structured through the literature seeks to bring more detailed information about these strategies. Accordingly, the results showed that Moroccan pharmaceutical firms focus on some crucial activities such as supplier selection, flexible control, supplier control, vendor verification, and inventory management to account for supply and demand risk. Empirical studies in the field of pharmaceutical risk management are rare. Thus, the goal of this work is address the scarcity of empirical studies in this field by outlining several key risk management strategies used by pharmaceutical supply chain laboratories in the context of Morocco which are putting more resources into these vital strategies. Most of the supply and demand techniques of these firms are found to be proactive .

Publisher

Altinbas University

Reference69 articles.

1. [1] Knemeyer, A. M., Zinn, W. and Eroglu, C., https://revues.imist.ma/index.php/REMAC/article/download/14912/12660 (accessed Jan. 04, 2022).

2. [2] U. Jüttner, H. Peck, and M. Christopher, “Supply chain risk management: outlining an agenda for future research,” International Journal of Logistics Research and Applications, vol. 6, no. 4, pp. 197–210, Dec. 2003, doi: 10.1080/13675560310001627016.

3. [3] G. Mehralian, A. R. Gatari, M. Morakabati, and H. Vatanpour, “Developing a Suitable Model for Supplier Selection Based on Supply Chain Risks: An Empirical Study from Iranian Pharmaceutical Companies,” p. 12, 2012.

4. [4] J. Opata and J. Opata, This Dissertation is brought to you for free and open access by ScholarWorks. It has been accepted for inclusion in Walden Dissertations and Doctoral. 2015.

5. [5] T. Jambulingam, R. Kathuria, and J. R. Nevin, “How fairness garners loyalty in the pharmaceutical supply chain: Role of trust in the wholesaler‐pharmacy relationship,” Intl J of Pharm & Health Mrkt, vol. 3, no. 4, pp. 305–322, Nov. 2009, doi: 10.1108/17506120911006029.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3